Show All
On what stock exchange are Syndax Pharmaceuticals, Inc.'s shares traded, and what is the ticker symbol?

Our common stock is traded on the NASDAQ Global Select Market under the symbol “SNDX.”

When was Syndax Pharmaceuticals, Inc.'s Initial Public Offering?

Our common stock first began trading on the NASDAQ Global Select Market in March 2016.

How can I buy or sell Syndax Pharmaceuticals, Inc.'s common stock?

You may purchase shares of our common stock through any brokerage, bank or other financial institution that is authorized to trade in shares of publicly held securities.

Where is Syndax Pharmaceuticals, Inc.'s corporate headquarters?

35 Gatehouse Drive
Building D, Floor 3
Waltham, Massachusetts 02451

When and where was Syndax Pharmaceuticals, Inc. incorporated?

We were incorporated in Delaware on October 11, 2005.

Who are the members of Syndax Pharmaceuticals, Inc.'s Board of Directors?

You can view our Board of Directors by visiting the Investor Relations – Corporate Governance page of our website.

Who are the members of Syndax Pharmaceuticals, Inc.'s management team?

You can view our management team by visiting the Management page of our website.

When does Syndax Pharmaceuticals, Inc.'s fiscal year end?

Our fiscal year ends on December 31 of each year.

Who is Syndax Pharmaceuticals, Inc.'s independent registered public accounting firm?

Our independent registered public accounting firm is Deloitte & Touche LLP.

Does Syndax Pharmaceuticals, Inc. pay dividends?

We have never declared or paid any cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business and do not intend to declare or pay any cash dividends in the foreseeable future.

Does Syndax Pharmaceuticals, Inc. have a dividend reinvestment plan?

No, because we do not currently pay dividends, we do not offer a dividend reinvestment plan.

Does Syndax Pharmaceuticals, Inc. have a direct stock purchase program?

No, we do not sell stock directly to the public.

What is Syndax Pharmaceuticals, Inc.'s CUSIP number?

Our CUSIP number is 87164F 105.

When does Syndax Pharmaceuticals, Inc. release earnings information?

Our fiscal year ends on December 31 of each year, with quarters ending on March 31, June 30 and September 30. Information regarding the timing of our earnings releases may be in the Investors – Press Releases and Investors – Events & Presentations pages of our website.

Where can I find additional information about Syndax Pharmaceuticals, Inc.?

You may find our press releases, quarterly and annual reports, as well as other filings with the Securities and Exchange Commission, on the Investors page of our website.

How do I report a change of mailing address?

You must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A.,, by U.S. mail. Each stockholder in question must sign a request for an address change.



How do I contact Syndax Pharmaceuticals, Inc.'s Investor Relations with a question or request?

You can contact our Investor Relations Department by filling out the form located on the Investor Relations – Contact Us page of our website.

How can I contact Syndax Pharmaceuticals, Inc.'s transfer agent?

Our transfer agent is Computershare Trust Company, N.A. Our transfer agent may be contacted at:


Computershare Trust Company, N.A.
480 Washington Blvd.
College Station, Texas 77845
Tel: 1-877-373-6374


You can find more information about how to contact Computershare Trust Company, N.A. at